MDT (STOCKS)
Medtronic plc
$101.900000
+0.480000 (+0.47%)
Prev close: $101.420000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Geoffrey Straub Martha
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $129,534.29M
- Employees
- 95,000
- P/E (TTM)
- 27.40
- P/B (TTM)
- 2.67
- Dividend Yield
- 279.04%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
13
Buy
14
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q2)
|
$1.36 | $1.33 | +0.0323 | +2.43% |
|
Sep 2025 (Q1)
|
$1.26 | $1.24 | +0.0184 | +1.48% |
|
Jun 2025 (Q4)
|
$1.62 | $1.59 | +0.0254 | +1.59% |
|
Mar 2025 (Q3)
|
$1.39 | $1.37 | +0.0166 | +1.21% |
Financial Statements
| Revenues | $17.52B |
| Benefits Costs and Expenses | $9.66B |
| Cost Of Revenue | $4.55B |
| Costs And Expenses | $9.66B |
| Gross Profit | $12.98B |
| Nonoperating Income/Loss | -$197.00M |
| Operating Expenses | $9.20B |
| Selling, General, and Administrative Expenses | $6.04B |
| Other Operating Expenses | $3.16B |
| Operating Income/Loss | $3.78B |
| Income/Loss Before Equity Method Investments | $3.78B |
| Income/Loss From Continuing Operations After Tax | $3.12B |
| Income/Loss From Continuing Operations Before Tax | $7.87B |
| Income Tax Expense/Benefit | $656.00M |
| Net Income/Loss | $3.12B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $3.12B |
| Net Income/Loss Available To Common Stockholders, Basic | $3.12B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $3.16 |
| Diluted Earnings Per Share | $3.12 |
| Basic Average Shares | 986,000,000 |
| Diluted Average Shares | 998,100,000 |
| Assets | $55.23B |
| Current Assets | $38.16B |
| Inventory | $1.88B |
| Other Current Assets | $36.29B |
| Noncurrent Assets | $17.07B |
| Fixed Assets | $2.33B |
| Intangible Assets | $2.34B |
| Other Non-current Assets | $12.41B |
| Liabilities | $35.06B |
| Current Liabilities | $5.61B |
| Accounts Payable | $635.00M |
| Other Current Liabilities | $4.98B |
| Noncurrent Liabilities | $29.45B |
| Equity | $20.17B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $20.17B |
| Liabilities And Equity | $55.23B |
| Net Cash Flow From Operating Activities | $4.32B |
| Net Cash Flow From Operating Activities, Continuing | $4.32B |
| Net Cash Flow From Investing Activities | -$2.37B |
| Net Cash Flow From Investing Activities, Continuing | -$2.37B |
| Net Cash Flow From Financing Activities | $14.08B |
| Net Cash Flow From Financing Activities, Continuing | $14.08B |
| Exchange Gains/Losses | -$104.00M |
| Net Cash Flow | $15.93B |
| Net Cash Flow, Continuing | $16.03B |
| Comprehensive Income/Loss | $3.06B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $3.06B |
| Other Comprehensive Income/Loss | -$64.00M |